Impact of the COVID-19 Pandemic on Family Planning
Impact of the COVID-19 Pandemic on Family Planning
Two year after the COVID-19 Pandemic broke out, emerging evidence suggests the impact of this disease has been limited. During this time, fewer women sought family planning services and the distribution of personal protective equipment remained unaffected. In addition, many facilities in the private sector were closed because of fears about the spread of the disease. However, this should not be interpreted as a complete failure of the family planning system.
The impact of the COVID-19 Pandemic has been overwhelmingly negative. It has created significant barriers to accessing family planning and has changed women’s preferences and behaviors. As a result, it has compounded existing social inequities by causing disproportionately poorer and Hispanic women to want more children. While this pandemic has been a huge challenge for women’s reproductive health, it is important to note that women in low-income countries, particularly those of color, may have been negatively affected more than women in higher-income nations.
Despite these concerns, the pandemic has been a major setback for family planning.
According to the MSI 2020b scenario, the impact of COVID-19 could cause the proportion of women with family planning needs to drop to 71 per cent by 2020, the lowest level since 1995. Sub-Saharan Africa and Latin America would experience the biggest declines, as their method mix is skewed towards short-term methods. Female sterilization would be the least affected area, and the impact of the pandemic would be smaller, if any.
Nevertheless, this situation is not as dire as some experts may think. Despite the looming threat of COVID-19, the impact of the epidemic on family planning services is likely to be modest. The majority of women in the world will still need some form of contraception to prevent unwanted pregnancies and a spike in STIs. The shortage of contraceptives and the lack of access to health care are the primary causes of unintended pregnancy, but this could mean serious consequences for a woman’s life.
As a result of the COVID-19 Pandemic, the percentage of women who have family planning needs will fall to 71 per cent by 2020. This is the lowest level since 1995. The biggest declines would be seen in South and Latin America, where the type of contraceptive methods is skewed towards short-term methods. The least affected countries are those in Central and Southern Asia where female sterilization is high.
Get India’s Best Family Planning Guidance
In addition to the reduction of fecundity, the COVID-19 outbreak has also impacted the supply of contraceptive commodities. The availability of these essential services has been disrupted. The availability of contraceptive products is at an all-time low. While the impact of the COVID-19 pandemic has been felt globally, it is unlikely to have a large impact on the number of women who have children.
Despite the widespread nature of the disease, it is unlikely that COVID-19 will have a substantial impact on the amount of contraceptive commodities in a given country. Nevertheless, the disruptions in the supply chain will affect the availability of contraceptive commodities, including the supply chain of contraceptives. This disruption will have a major impact on the cost and availability of family planning.
The extent of disruptions in the supply chain will be determined by the MSI 2020b scenario. By 2022, the global contraceptive prevalence will be lower than the prevalence estimated in 2020. The MSI scenario assumes no changes in sexual activity, fertility intentions, or total demand for family planning services. In other words, the impact of the COVID-19 pandemic will have a positive effect on the supply of contraceptive commodities.
A study from the United Nations focuses on the impact of the COVID-19 pandemic on the global fertility rate. The UN reports that the prevalence of contraceptive methods in 2020 will be higher than the prevalence in 2015 because of the lack of a COVID-19-infected vaccine. The WHO estimates that the number of contraceptive methods will double worldwide by 2025.
